Belly fat may hold key to ulcerative colitis treatment success

NCT ID NCT07126015

Not yet recruiting Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether measuring visceral fat (belly fat) using CT scans can predict how well ulcerative colitis patients respond to biologic therapy. Researchers will follow 200 adults with active ulcerative colitis for 6 months, tracking changes in fat volume and treatment outcomes. The goal is to find a simple way to personalize treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict which ulcerative colitis patients will benefit from biologic therapy, leading to more personalized treatment.
What could go wrong: This is an observational study, not a treatment trial. It may not find a clear link between visceral fat and treatment response, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDICTING BIOLOGICS SUCCESS VIA VAT ASSESSMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREDICTING BIOLOGICS SUCCESS VIA VAT ASSESSMENT

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.